Add-on·Healthcare/Pharma Services·June 18, 2026
Premier Biotech adds NexScreen and TransMed
The combination adds point-of-care testing, drug testing products and laboratory supplies, extending the platform's reach into Australia and New Zealand.
Takeaways
- NexScreen and TransMed is a point-of-care diagnostic testing, drug testing products, and laboratory supplies.
- The target serves healthcare, government, workplace across United States, Australia, New Zealand.
TargetNexScreen and TransMed
SponsorAlign Capital Partners
TypeAdd-on
GeographyUnited States, Australia, New Zealand
IndustryHealthcare
Sub-sectorPharma Services
The add-ons expand the company’s rapid testing portfolio and add distribution reach across the United States, Australia and New Zealand.
Daily PE deal brief
Get Buyout Desk email updates.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up on the site. Email updates are not on a fixed schedule.